Verve Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Verve Therapeutics's balance sheet done over the years? Its assets were worth $752,688,000 last year, which is more than in the previous period. 20% of Verve Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $153,186,000, which means an increase by 19% compared compared to last year.

Debt to Assets

Verve Therapeutics, Inc. (NASDAQ:VERV): Debt to assets
2019 21647000 41.2M 190.33%
2020 78413000 142.32M 181.5%
2021 384124000 26.77M 6.97%
2022 679223000 128.29M 18.89%
2023 752688000 153.18M 20.35%

VERV Balance Sheet (2019 – 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
206.18M115.41M64.33M8.99M2.98M
Short term investments
417.77M439.39M296.11M63.11M15.79M
Net receivables
5.89M1.01M000
Inventory
01000
Other current assets
8.10M7.33M6.68M1.85M272K
Total current assets
637.94M563.15M367.12M73.96M19.05M
Non-current assets:
Property, Plant and Equipment
107.8M110.65M9.06M3.98M2.35M
Goodwill
00000
Intangible assets
00000
Long term investments
04.82M5.23M463K235K
Other non-current assets
6.93M585K2.69M00
Total non-current assets
114.73M116.06M16.99M4.44M2.59M
Total assets
752.68M679.22M384.12M78.41M21.64M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
020.01M-12.99M90K31K
Short term debt
20.38M11.90M1.95M-90K-31K
Total current liabilities
37.00M35.09M22.02M7.31M3.55M
Non-current liabilities:
Long term debt
64.71M70.01M0125.16M35.05M
Deferred tax
00000
Other non-current liabilities
2.90M3.16M4.74M135.00M37.64M
Total non-current liabilities
116.18M93.19M4.74M135.00M37.64M
Total liabilities
153.18M128.29M26.77M142.32M41.2M
Data sourceData sourceData source